title: Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease.
abstract: Neuronal iron homeostasis disruption and oxidative stress are closely related to the pathogenesis of Parkinson's disease (PD). Adult iron-regulatory protein 2 knockout (Ireb2(-/-)) mice develop iron accumulation in white matter tracts and nuclei in different brain area and display severe neurodegeneration in Purkinje cells of the cerebrum. Mitochondrial ferritin (MtFt), a newly discovered ferritin, specifically expresses in high energy-consuming cells, including neurons of brain and spinal cord. Interestingly, the decreased expression of MtFt in cerebrum, but not in striatum, matches the differential neurodegeneration pattern in these Ireb2(-/-) mice. To explore its effect on neurodegeneration, the effects of MtFt expression on 6-hydrodopamine (6-OHDA)-induced neuronal damage was examined. The overexpression of MtFt led to a cytosolic iron deficiency in the neuronal cells and significantly prevented the alteration of iron redistribution induced by 6-OHDA. Importantly, MtFt strongly inhibited mitochondrial damage, decreased production of the reactive oxygen species and lipid peroxidation, and dramatically rescued apoptosis by regulating Bcl-2, Bax and caspase-3 pathways. In conclusion, this study demonstrates that MtFt plays an important role in preventing neuronal damage in an 6-OHDA-induced parkinsonian phenotype by maintaining iron homeostasis. Regulation of MtFt expression in neuronal cells may provide a new neuroprotective strategy for PD.
authors.affiliation: Laboratory of Molecular Iron Metabolism, College of Life Science, Hebei Normal University, Shijiazhuang, Hebei Province, China.
authors.forename: Zhen-Hua
authors.initials: ZH
authors.lastname: Shi
authors.forename: Guangjun
authors.initials: G
authors.lastname: Nie
authors.forename: Xiang-Lin
authors.initials: XL
authors.lastname: Duan
authors.forename: Tracey
authors.initials: T
authors.lastname: Rouault
authors.forename: Wen-Shuang
authors.initials: WS
authors.lastname: Wu
authors.forename: Bo
authors.initials: B
authors.lastname: Ning
authors.forename: Nan
authors.initials: N
authors.lastname: Zhang
authors.forename: Yan-Zhong
authors.initials: YZ
authors.lastname: Chang
authors.forename: Bao-Lu
authors.initials: BL
authors.lastname: Zhao
mesh_terms: D000818:Animals; D017209:Apoptosis; D053148:Caspase 3 / Q000378:metabolism; D002460:Cell Line; D019610:Cytoprotection; D005293:Ferritins / Q000235:genetics / Q000378:metabolism*; D006892:Hydroxydopamines / Q000378:metabolism*; D035942:Iron Regulatory Protein 2 / Q000172:deficiency / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D008928:Mitochondria / Q000378:metabolism*; D010300:Parkinson Disease / Q000378:metabolism*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism
chemical_list: D006892:Hydroxydopamines; D019253:Proto-Oncogene Proteins c-bcl-2; D005293:Ferritins; C505407:CASP3 protein, human; D053148:Caspase 3; D035942:Iron Regulatory Protein 2